Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
2(15%)
Results Posted
57%(4 trials)
Terminated
2(15%)

Phase Distribution

Ph phase_3
1
8%
Ph phase_2
5
38%
Ph early_phase_1
1
8%
Ph phase_4
4
31%
Ph not_applicable
2
15%

Phase Distribution

1

Early Stage

5

Mid Stage

5

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 2Efficacy & side effects
5(38.5%)
Phase 3Large-scale testing
1(7.7%)
Phase 4Post-market surveillance
4(30.8%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(7)
Terminated(2)
Other(2)

Detailed Status

Completed7
Active, not recruiting2
unknown2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.7%)
Phase 25 (38.5%)
Phase 31 (7.7%)
Phase 44 (30.8%)
N/A2 (15.4%)

Trials by Status

active_not_recruiting215%
unknown215%
terminated215%
completed754%

Recent Activity

2 active trials
Showing 5 of 13
completednot_applicable

Altering Activation Patterns Post-stroke

NCT02418949
active_not_recruitingphase_2

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

NCT04488081
active_not_recruitingphase_4

The Use of Cyproheptadine in Pediatric Feeding Disorders

NCT06751290
completedphase_2

Pediatric Oncology Nutrition Intervention Trial

NCT06175273
completedphase_2

Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects

NCT04108104
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT02418949Not Applicable

Altering Activation Patterns Post-stroke

Completed
NCT04488081Phase 2

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Active Not Recruiting
NCT06751290Phase 4

The Use of Cyproheptadine in Pediatric Feeding Disorders

Active Not Recruiting
NCT06175273Phase 2

Pediatric Oncology Nutrition Intervention Trial

Completed
NCT04108104Phase 2

Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects

Completed
NCT04979221Phase 3

Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19

Unknown
NCT02568007Phase 4

Effects of Cyproheptadine on Growth and Behavior in Pediatric Feeding Disorders

Terminated
NCT01675050Phase 2

A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain

Terminated
NCT01688570Early Phase 1

Mechanisms of Neuromuscular Fatigue Post Stroke

Completed
NCT01538693Not Applicable

Molecular Markers of Neuroplasticity During Exercise in People With Incomplete Spinal Cord Injury

Completed
NCT01940978Phase 4

A Study of Combination Therapy in Children With ADHD

Completed
NCT01076283Phase 2

A Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking

Completed
NCT01314989Phase 4

Cyproheptadine as an Appetite Stimulant

Unknown

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13